XFOR · X4 Pharmaceuticals, Inc
$4.03
+0.10 (+2.54%)
At close · Jul 29
Market Cap
$370.68M
Shares
94.32M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-01 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K/A | 2026-05-13 | 2026-05-11 | |
| 8-K | 2026-05-12 | 2026-05-11 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| DEF 14A | 2026-03-20 | — | |
| 10-K | 2026-03-17 | 2025-12-31 | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-27 | 2025-10-23 | |
| 8-K | 2025-09-17 | 2025-09-15 | |
| 8-K | 2025-08-25 | 2025-08-22 | |
| 8-K | 2025-08-13 | 2025-08-12 | |
| 8-K | 2025-08-12 | 2025-08-11 | |
| 10-Q | 2025-08-08 | 2025-06-30 | |
| 8-K | 2025-06-23 | — | |
| 8-K | 2025-06-11 | — | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-05-01 | — | |
| DEF 14A | 2025-04-25 | — | |
| 8-K | 2025-04-24 | — | |
| 8-K | 2025-04-18 | 2025-04-17 | |
| 10-K | 2025-03-26 | 2024-12-31 | |
| 8-K | 2025-03-25 | — | |
| DEF 14A | 2025-03-24 | — | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-02-06 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-08-16 | 2024-08-13 | |
| 8-K | 2024-08-09 | 2024-08-08 | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-19 | — | |
| 8-K | 2024-06-27 | — | |
| 8-K | 2024-06-11 | 2024-06-10 | |
| 8-K | 2024-05-22 | — | |
| 8-K | 2024-05-09 | 2024-05-08 | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-04-29 | — | |
| DEF 14A | 2024-04-29 | — | |
| 8-K | 2024-04-29 | — | |
| 8-K | 2024-04-05 | — | |
| 8-K | 2024-04-01 | — | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-21 | — | |
| 8-K | 2024-01-08 | — |
Showing 1–50 of 145 filings